LKFT
Lakefront Biotherapeutics N.V.- Healthcare
- Biotechnology
- $2.07B market cap
Forecast run · Oct 29, 2026Upside rank 2493 of 3,186
Model Signal
ForecastQ Daily Probabilities
11.7%
78.1%
6.9%
Analyst Consensus
Recommendation2.50/5 Buy
Last price$31.65
Price target$35.50
Implied move+12.2%
Analysts2
ForecastQ Portfolios
LKFT is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.